Devimistat is an investigational anti-mitochondrial agent and 2-amino-4-imidazoline derivative currently under evaluation in clinical trials for the treatment of various solid tumors, lymphoma, and pancreatic… Read more
Devimistat is an investigational anti-mitochondrial agent and 2-amino-4-imidazoline derivative currently under evaluation in clinical trials for the treatment of various solid tumors, lymphoma, and pancreatic cancer. To support rigorous analytical testing, this category offers a comprehensive selection of reference standards, including the active pharmaceutical ingredient, pharmacopeial and non-pharmacopeial impurities, and stable isotope-labelled compounds. Pharmaceutical laboratories utilize these high-quality materials for impurity profiling, method validation, and ongoing quality control throughout the development process. By providing precise standards for these related compounds—such as 6,8-bis[(phenylmethyl)thio]octanoic acid—researchers can ensure the accuracy and reliability of their quantitative assays. Accessing well-characterized reference materials is essential for verifying drug purity, identifying degradation products, and meeting regulatory requirements in the analysis of this complex anti-cancer candidate.